ABMD
Income statement / Annual
Last year (2022), Abiomed, Inc.'s total revenue was $1.03 B,
an increase of 21.74% from the previous year.
In 2022, Abiomed, Inc.'s net income was $136.51 M.
See Abiomed, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
Period Ended |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
03/31/2014 |
03/31/2013 |
Operating Revenue |
$1.03 B |
$847.52 M |
$840.88 M |
$769.43 M |
$593.75 M |
$445.30 M |
$329.54 M |
$230.31 M |
$183.64 M |
$158.12 M |
Cost of Revenue |
$188.16 M
|
$161.91 M
|
$151.31 M
|
$129.57 M
|
$98.58 M
|
$70.63 M
|
$50.42 M
|
$39.95 M
|
$37.32 M
|
$31.60 M
|
Gross Profit |
$843.60 M
|
$685.62 M
|
$689.58 M
|
$639.87 M
|
$495.17 M
|
$374.68 M
|
$279.12 M
|
$190.37 M
|
$146.32 M
|
$126.53 M
|
Gross Profit Ratio |
0.82
|
0.81
|
0.82
|
0.83
|
0.83
|
0.84
|
0.85
|
0.83
|
0.8
|
0.8
|
Research and Development Expenses |
$163.40 M
|
$121.88 M
|
$98.76 M
|
$93.50 M
|
$75.30 M
|
$66.39 M
|
$49.76 M
|
$35.97 M
|
$30.71 M
|
$25.65 M
|
General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$321.55 M
|
$262.73 M
|
$218.15 M
|
$164.26 M
|
$125.73 M
|
$107.25 M
|
$84.23 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$423.49 M
|
$334.18 M
|
$341.60 M
|
$321.55 M
|
$262.73 M
|
$218.15 M
|
$164.26 M
|
$125.73 M
|
$107.25 M
|
$84.23 M
|
Other Expenses |
$0.00
|
$51.95 M
|
-$4.56 M
|
$30.38 M
|
-$388,000.00
|
-$349,000.00
|
$339,000.00
|
-$97,000.00
|
$49,000.00
|
$326,000.00
|
Operating Expenses |
$586.89 M
|
$456.06 M
|
$440.36 M
|
$415.05 M
|
$338.03 M
|
$284.54 M
|
$214.02 M
|
$161.70 M
|
$137.96 M
|
$109.99 M
|
Cost And Expenses |
$775.05 M
|
$617.97 M
|
$591.66 M
|
$544.62 M
|
$436.61 M
|
$355.17 M
|
$264.44 M
|
$201.65 M
|
$175.28 M
|
$141.58 M
|
Interest Income |
$49.84 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$49.84 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$28.09 M
|
$17.38 M
|
$8.26 M
|
$14.12 M
|
$11.01 M
|
$6.20 M
|
$3.28 M
|
$2.77 M
|
$2.51 M
|
$2.72 M
|
EBITDA |
$400.78 M |
$246.94 M |
$257.48 M |
$230.77 M |
$164.45 M |
$94.79 M |
$67.99 M |
$31.24 M |
$10.75 M |
$19.27 M |
EBITDA Ratio |
0.39
|
0.29
|
0.31
|
0.3
|
0.28
|
0.21
|
0.21
|
0.14
|
0.06
|
0.12
|
Operating Income Ratio |
0.36
|
0.27
|
0.3
|
0.29
|
0.26
|
0.2
|
0.2
|
0.12
|
0.05
|
0.1
|
Total Other Income/Expenses Net |
-$182.13 M
|
$58.66 M
|
$7.61 M
|
$38.55 M
|
$3.30 M
|
$1.21 M
|
$734,000.00
|
$99,000.00
|
$167,000.00
|
$319,000.00
|
Income Before Tax |
$190.56 M
|
$288.22 M
|
$256.83 M
|
$263.36 M
|
$160.44 M
|
$91.34 M
|
$65.84 M
|
$28.77 M
|
$8.53 M
|
$16.86 M
|
Income Before Tax Ratio |
0.18
|
0.34
|
0.31
|
0.34
|
0.27
|
0.21
|
0.2
|
0.12
|
0.05
|
0.11
|
Income Tax Expense |
$54.06 M
|
$62.70 M
|
$53.82 M
|
$4.34 M
|
$48.27 M
|
$39.23 M
|
$27.69 M
|
-$84.92 M
|
$1.18 M
|
$1.85 M
|
Net Income |
$136.51 M
|
$225.53 M
|
$203.01 M
|
$259.02 M
|
$112.17 M
|
$52.12 M
|
$38.15 M
|
$113.69 M
|
$7.35 M
|
$15.01 M
|
Net Income Ratio |
0.13
|
0.27
|
0.24
|
0.34
|
0.19
|
0.12
|
0.12
|
0.49
|
0.04
|
0.09
|
EPS |
3 |
5 |
4.49 |
5.77 |
2.54 |
1.21 |
0.9 |
2.8 |
0.19 |
0.38 |
EPS Diluted |
2.98 |
4.94 |
4.43 |
5.61 |
2.45 |
1.17 |
0.85 |
2.65 |
0.18 |
0.37 |
Weighted Average Shares Out |
$45.45 M
|
$45.14 M
|
$45.18 M
|
$44.91 M
|
$44.15 M
|
$43.24 M
|
$42.20 M
|
$40.63 M
|
$39.33 M
|
$39.11 M
|
Weighted Average Shares Out Diluted |
$45.88 M
|
$45.67 M
|
$45.82 M
|
$46.15 M
|
$45.85 M
|
$44.66 M
|
$44.90 M
|
$42.86 M
|
$41.61 M
|
$41.05 M
|
Link |
|
|
|
|
|
|
|
|
|
|